Discover
HCAT
Health Catalyst, Inc.
2.07
2 x 1.59
1 x 2.06
bid
ask
+
0.08
4.02%
2 @ 04:55 AM
2.14 +0.07 (3.38%)
| Ytd | -13.39% | |
| 1y | -48.89% |
1.98
day range
2.24
0.95
52 week range
4.13
| Open | 1.99 | Prev Close | 1.99 | Low | 1.98 | High | 2.24 | Mkt Cap | 152.96M |
| Vol | 1.80M | Avg Vol | 1.50M | EPS | -3.73 | P/E | N/A | Forward P/E | 16.52 |
| Beta | 1.32 | Short Ratio | 5.03 | Inst. Own | 90.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.53 | 200-d Avg | 2.08 | 1yr Est | 11.41 |
| Income Statement | |||
| Total Revenue | 70.76M | ||
| Revenues (USD) | 70.76M | ||
| Cost of Revenue | 35.29M | ||
| Gross Profit | 35.46M | ||
| Operating Expenses | 141.94M | ||
| Research and Development Expense | 9.78M | ||
| Selling, General and Administrative Expense | 24.55M | ||
| Operating Income | -106.48M | ||
| Interest Expense | 4.14M | ||
| Income Tax Expense | 414.00K | ||
| Net Income | -111.03M | ||
| Net Income Common Stock | -111.03M | ||
| Net Income Common Stock (USD) | -111.03M | ||
| Consolidated Income | -111.03M | ||
| Earnings per Basic Share | -1.53 | ||
| Earnings per Basic Share (USD) | -1.53 | ||
| Earnings per Diluted Share | -1.53 | ||
| Earning Before Interest & Taxes (EBIT) | -106.48M | ||
| Earning Before Interest & Taxes (USD) | -106.48M | ||
| Weighted Average Shares | 72.59M | ||
| Weighted Average Shares Diluted | 72.59M | ||
| Balance Sheet | |||
| Cash and Equivalents | 59.86M | ||
| Cash and Equivalents (USD) | 59.86M | ||
| Investments | 48.96M | ||
| Investments Current | 48.96M | ||
| Trade and Non-Trade Receivables | 59.15M | ||
| Current Assets | 182.31M | ||
| Property, Plant & Equipment Net | 41.19M | ||
| Total Assets | 412.20M | ||
| Debt Current | 5.36M | ||
| Total Debt | 170.58M | ||
| Current Liabilities | 107.61M | ||
| Debt Non-Current | 165.22M | ||
| Total Liabilities | 274.06M | ||
| Accumulated Retained Earnings (Deficit) | -1.48B | ||
| Accumulated Other Comprehensive Income | 1.01M | ||
| Shareholders Equity | 138.15M | ||
| Shareholders Equity (USD) | 138.15M | ||
| Assets Non-Current | 229.89M | ||
| Total Debt (USD) | 170.58M | ||
| Deferred Revenue | 69.96M | ||
| Goodwill and Intangible Assets | 182.58M | ||
| Liabilities Non-Current | 166.44M | ||
| Trade and Non-Trade Payables | 11.69M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 12.74M | ||
| Net Cash Flow from Financing | -4.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.05M | ||
| Capital Expenditure | -4.94M | ||
| Issuance (Purchase) of Equity Shares | 403.00K | ||
| Issuance (Repayment) of Debt Securities | -407.00K | ||
| Net Cash Flow from Investing | -9.41M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.91M | ||
| Net Cash Flow from Operations | 18.51M | ||
| Effect of Exchange Rate Changes on Cash | -51.00K | ||
| Share Based Compensation | 3.77M | ||